MiMedx Group, Inc. Research and Development Expense
MiMedx Group, Inc. (MDXG) reported Research and Development Expense of $2.78 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-29.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2026-07-29
- MiMedx Group, Inc. research and development expense for the quarter ending 2026-06-30 was $2.78M, a 15.92% decline year-over-year.
- MiMedx Group, Inc. research and development expense for the quarter ending 2026-03-31 was $4.14M, a 24.40% increase year-over-year.
- MiMedx Group, Inc. research and development expense for the quarter ending 2025-12-31 was $4.76M, a 33.32% increase year-over-year.
- MiMedx Group, Inc. research and development expense for the quarter ending 2025-09-30 was $3.70M, a 26.90% increase year-over-year.
- MiMedx Group, Inc. research and development expense for fiscal 2025 was $15.10M, a 22.33% increase from fiscal 2024.
- MiMedx Group, Inc. research and development expense for fiscal 2024 was $12.34M, a 2.56% decline from fiscal 2023.
- MiMedx Group, Inc. research and development expense for fiscal 2023 was $12.66M, a 0.28% decline from fiscal 2022.
- MiMedx Group, Inc. research and development expense for fiscal 2022 was $12.70M, a 27.88% increase from fiscal 2021.
| Period end | Research and Development Expense 3 month | Research and Development Expense 3 month as first filed | Research and Development Expense 6 month | Research and Development Expense 6 month as first filed | Research and Development Expense 9 month | Research and Development Expense 9 month as first filed | Research and Development Expense 12 month | Research and Development Expense 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $2.78M 10-Q · filed 2026-07-29 | $6.92M 10-Q · filed 2026-07-29 | $11.68M derived: sum of 3 quarters · filed 2026-07-29 | $15.38M derived: sum of 4 quarters · filed 2026-07-29 | ||||
| 2026-03-31 | $4.14M 10-Q · filed 2026-04-29 | $8.90M derived: sum of 2 quarters · filed 2026-04-29 | $12.60M derived: sum of 3 quarters · filed 2026-04-29 | $15.91M derived: sum of 4 quarters · filed 2026-07-29 | ||||
| 2025-12-31 | $4.76M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $8.46M derived: sum of 2 quarters · filed 2026-02-25 | $11.77M derived: sum of 3 quarters · filed 2026-07-29 | $15.10M 10-K · filed 2026-02-25 | ||||
| 2025-09-30 | $3.70M 10-Q · filed 2025-10-29 | $7.01M derived: sum of 2 quarters · filed 2026-07-29 | $10.34M 10-Q · filed 2025-10-29 | $13.90M derived: sum of 4 quarters · filed 2026-07-29 | ||||
| 2025-06-30 | $3.30M 10-Q · filed 2026-07-29 | $6.63M 10-Q · filed 2026-07-29 | $10.20M derived: sum of 3 quarters · filed 2026-07-29 | $13.12M derived: sum of 4 quarters · filed 2026-07-29 | ||||
| 2025-03-31 | $3.33M 10-Q · filed 2026-04-29 | $6.90M derived: sum of 2 quarters · filed 2026-04-29 | $9.82M derived: sum of 3 quarters · filed 2026-04-29 | $12.83M derived: sum of 4 quarters · filed 2026-04-29 | ||||
| 2024-12-31 | $3.57M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $6.49M derived: sum of 2 quarters · filed 2026-02-25 | $9.50M derived: sum of 3 quarters · filed 2026-02-25 | $12.34M 10-K · filed 2026-02-25 | ||||
| 2024-09-30 | $2.92M 10-Q · filed 2025-10-29 | $5.93M derived: sum of 2 quarters · filed 2025-10-29 | $8.77M 10-Q · filed 2025-10-29 | $11.20M derived: sum of 4 quarters · filed 2026-02-25 | ||||
| 2024-06-30 | $3.01M 10-Q · filed 2025-07-30 | $5.85M 10-Q · filed 2025-07-30 | $8.29M derived: sum of 3 quarters · filed 2026-02-25 | $11.36M derived: sum of 4 quarters · filed 2026-02-25 | ||||
| 2024-03-31 | $2.84M 10-Q · filed 2025-04-30 | $5.27M derived: sum of 2 quarters · filed 2026-02-25 | $8.35M derived: sum of 3 quarters · filed 2026-02-25 | $12.02M derived: sum of 4 quarters · filed 2026-02-25 | ||||
| 2023-12-31 | $2.43M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $5.51M derived: sum of 2 quarters · filed 2026-02-25 | $9.18M derived: sum of 3 quarters · filed 2026-02-25 | $12.66M 10-K · filed 2026-02-25 | ||||
| 2023-09-30 | $3.08M 10-Q · filed 2024-10-30 | $3.17M 10-Q · filed 2023-10-30 | $6.75M derived: sum of 2 quarters · filed 2024-10-30 | $10.23M 10-Q · filed 2024-10-30 | $18.17M 10-Q · filed 2023-10-30 | $5.50M derived: sum of 4 quarters · filed 2025-02-26 | ||
| 2023-06-30 | $3.67M 10-Q · filed 2024-07-31 | $8.50M 10-Q · filed 2023-08-01 | $7.16M 10-Q · filed 2024-07-31 | $14.99M 10-Q · filed 2023-08-01 | $2.43M derived: sum of 3 quarters · filed 2025-02-26 | $8.38M derived: sum of 4 quarters · filed 2025-02-26 | ||
| 2023-03-31 | $3.48M 10-Q · filed 2024-04-30 | $6.50M 10-Q · filed 2023-05-02 | -$1.24M derived: sum of 2 quarters · filed 2025-02-26 | $4.71M derived: sum of 3 quarters · filed 2025-02-26 | $10.22M derived: sum of 4 quarters · filed 2025-02-26 | |||
| 2022-12-31 | -$4.73M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-26 | $1.23M derived: sum of 2 quarters · filed 2025-02-26 | $6.74M derived: sum of 3 quarters · filed 2025-02-26 | $12.70M 10-K · filed 2025-02-26 | $22.83M 10-K · filed 2023-02-28 | |||
| 2022-09-30 | $5.95M 10-Q · filed 2023-10-30 | $11.46M derived: sum of 2 quarters · filed 2023-10-30 | $17.43M 10-Q · filed 2023-10-30 | $14.59M derived: sum of 4 quarters · filed 2024-02-28 | ||||
| 2022-06-30 | $5.51M 10-Q · filed 2023-08-01 | $11.48M 10-Q · filed 2023-08-01 | $8.64M derived: sum of 3 quarters · filed 2024-02-28 | $13.01M derived: sum of 4 quarters · filed 2024-02-28 | ||||
| 2022-03-31 | $5.96M 10-Q · filed 2023-05-02 | $3.13M derived: sum of 2 quarters · filed 2024-02-28 | $7.49M derived: sum of 3 quarters · filed 2024-02-28 | $11.56M derived: sum of 4 quarters · filed 2024-02-28 | ||||
| 2021-12-31 | -$2.84M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $1.53M derived: sum of 2 quarters · filed 2024-02-28 | $5.59M derived: sum of 3 quarters · filed 2024-02-28 | $9.93M 10-K · filed 2024-02-28 | $17.34M 10-K · filed 2022-02-28 | |||
| 2021-09-30 | $4.37M 10-Q · filed 2022-11-02 | $8.43M derived: sum of 2 quarters · filed 2022-11-02 | $12.77M 10-Q · filed 2022-11-02 | $16.20M derived: sum of 4 quarters · filed 2023-02-28 | ||||
| 2021-06-30 | $4.06M 10-Q · filed 2022-08-02 | $8.40M 10-Q · filed 2022-08-02 | $11.84M derived: sum of 3 quarters · filed 2023-02-28 | $15.21M derived: sum of 4 quarters · filed 2023-02-28 | ||||
| 2021-03-31 | $4.34M 10-Q · filed 2022-05-03 | $7.77M derived: sum of 2 quarters · filed 2023-02-28 | $11.14M derived: sum of 3 quarters · filed 2023-02-28 | $13.40M derived: sum of 4 quarters · filed 2023-02-28 | ||||
| 2020-12-31 | $3.43M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $6.81M derived: sum of 2 quarters · filed 2023-02-28 | $9.06M derived: sum of 3 quarters · filed 2023-02-28 | $11.71M 10-K · filed 2023-02-28 | ||||
| 2020-09-30 | $3.37M 10-Q · filed 2021-11-02 | $5.63M derived: sum of 2 quarters · filed 2021-11-02 | $8.28M 10-Q · filed 2021-11-02 | $11.00M derived: sum of 4 quarters · filed 2022-02-28 | ||||
| 2020-06-30 | $2.26M 10-Q · filed 2021-08-03 | $4.91M 10-Q · filed 2021-08-03 | $7.63M derived: sum of 3 quarters · filed 2022-02-28 | $10.32M derived: sum of 4 quarters · filed 2022-02-28 | ||||
| 2020-03-31 | $2.65M 10-Q · filed 2021-04-28 | $5.37M derived: sum of 2 quarters · filed 2022-02-28 | $8.06M derived: sum of 3 quarters · filed 2022-02-28 | $10.89M derived: sum of 4 quarters · filed 2022-02-28 | ||||
| 2019-12-31 | $2.72M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $5.41M derived: sum of 2 quarters · filed 2022-02-28 | $8.24M derived: sum of 3 quarters · filed 2022-02-28 | $11.14M 10-K · filed 2022-02-28 | ||||
| 2019-09-30 | $2.69M 10-Q · filed 2020-11-04 | $5.52M derived: sum of 2 quarters · filed 2020-11-04 | $8.42M 10-Q · filed 2020-11-04 | $12.96M derived: sum of 4 quarters · filed 2021-03-08 | ||||
| 2019-06-30 | $2.83M 10-Q · filed 2020-08-04 | $5.73M 10-Q · filed 2020-08-04 | $10.27M derived: sum of 3 quarters · filed 2021-03-08 | $14.23M derived: sum of 4 quarters · filed 2021-03-08 | ||||
| 2019-03-31 | $2.90M 10-Q · filed 2020-07-06 | $7.44M derived: sum of 2 quarters · filed 2021-03-08 | $11.40M derived: sum of 3 quarters · filed 2021-03-08 | $15.12M derived: sum of 4 quarters · filed 2021-03-08 | ||||
| 2018-12-31 | $4.54M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-08 | $8.50M derived: sum of 2 quarters · filed 2021-03-08 | $12.22M derived: sum of 3 quarters · filed 2021-03-08 | $15.77M 10-K · filed 2021-03-08 | ||||
| 2018-09-30 | $3.96M 10-Q · filed 2020-07-06 | $7.68M derived: sum of 2 quarters · filed 2020-07-06 | $11.22M 10-Q · filed 2020-07-06 | $14.70M derived: sum of 4 quarters · filed 2020-07-06 | ||||
| 2018-06-30 | $3.72M 10-Q · filed 2020-07-06 | $7.26M 10-Q · filed 2020-07-06 | $10.73M derived: sum of 3 quarters · filed 2020-07-06 | $16.21M derived: sum of 4 quarters · filed 2020-07-06 | ||||
| 2018-03-31 | $3.54M 10-Q · filed 2020-07-06 | $7.01M derived: sum of 2 quarters · filed 2020-07-06 | $12.50M derived: sum of 3 quarters · filed 2020-07-06 | $17.24M derived: sum of 4 quarters · filed 2020-07-06 | ||||
| 2017-12-31 | $3.47M derived: 10-K 12 month − 10-Q 9 month · filed 2020-07-06 | $8.95M derived: sum of 2 quarters · filed 2020-07-06 | $13.70M derived: sum of 3 quarters · filed 2020-07-06 | $17.90M 10-K · filed 2020-07-06 | ||||
| 2017-09-30 | $5.48M 10-Q · filed 2017-10-31 | $10.23M derived: sum of 2 quarters · filed 2017-10-31 | $14.43M 10-Q · filed 2017-10-31 | $20.19M derived: sum of 4 quarters · filed 2020-03-17 | ||||
| 2017-06-30 | $4.75M 10-Q · filed 2017-07-31 | $8.95M 10-Q · filed 2017-07-31 | $14.71M derived: sum of 3 quarters · filed 2020-03-17 | $17.63M derived: sum of 4 quarters · filed 2020-03-17 | ||||
| 2017-03-31 | $4.20M 10-Q · filed 2017-05-01 | $9.96M derived: sum of 2 quarters · filed 2020-03-17 | $12.88M derived: sum of 3 quarters · filed 2020-03-17 | $16.05M derived: sum of 4 quarters · filed 2020-03-17 | ||||
| 2016-12-31 | $5.76M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-17 | $8.68M derived: sum of 2 quarters · filed 2020-03-17 | $11.85M derived: sum of 3 quarters · filed 2020-03-17 | $14.34M 10-K · filed 2020-03-17 | $12.04M 10-K · filed 2017-03-01 | |||
| 2016-09-30 | $2.92M 10-Q · filed 2017-10-31 | $6.09M derived: sum of 2 quarters · filed 2017-10-31 | $8.58M 10-Q · filed 2017-10-31 | $10.92M derived: sum of 4 quarters · filed 2017-10-31 | ||||
| 2016-06-30 | $3.17M 10-Q · filed 2017-07-31 | $5.66M 10-Q · filed 2017-07-31 | $8.01M derived: sum of 3 quarters · filed 2017-07-31 | $10.19M derived: sum of 4 quarters · filed 2017-07-31 | ||||
| 2016-03-31 | $2.50M 10-Q · filed 2017-05-01 | $4.84M derived: sum of 2 quarters · filed 2017-05-01 | $7.02M derived: sum of 3 quarters · filed 2017-05-01 | $9.08M derived: sum of 4 quarters · filed 2017-05-01 | ||||
| 2015-12-31 | $2.34M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01 | $4.53M derived: sum of 2 quarters · filed 2017-03-01 | $6.58M derived: sum of 3 quarters · filed 2017-03-01 | $8.41M 10-K · filed 2017-03-01 | ||||
| 2015-09-30 | $2.19M 10-Q · filed 2016-11-08 | $4.24M derived: sum of 2 quarters · filed 2016-11-08 | $6.07M 10-Q · filed 2016-11-08 | $7.92M derived: sum of 4 quarters · filed 2017-03-01 | ||||
| 2015-06-30 | $2.05M 10-Q · filed 2016-08-02 | $3.88M 10-Q · filed 2016-08-02 | $5.73M derived: sum of 3 quarters · filed 2017-03-01 | $7.75M derived: sum of 4 quarters · filed 2017-03-01 | ||||
| 2015-03-31 | $1.83M 10-Q · filed 2016-05-10 | $3.68M derived: sum of 2 quarters · filed 2017-03-01 | $5.69M derived: sum of 3 quarters · filed 2017-03-01 | $7.49M derived: sum of 4 quarters · filed 2017-03-01 | ||||
| 2014-12-31 | $1.85M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01 | $3.86M derived: sum of 2 quarters · filed 2017-03-01 | $5.66M derived: sum of 3 quarters · filed 2017-03-01 | $7.05M 10-K · filed 2017-03-01 | ||||
| 2014-09-30 | $2.01M 10-Q · filed 2015-11-06 | $2.01M 10-Q · filed 2014-11-10 | $3.81M derived: sum of 2 quarters · filed 2015-11-06 | $5.20M 10-Q · filed 2015-11-06 | $5.20M 10-Q · filed 2014-11-10 | $6.59M derived: sum of 4 quarters · filed 2017-02-22 | ||
| 2014-06-30 | $1.80M 10-Q · filed 2015-08-07 | $1.80M 10-Q · filed 2014-08-11 | $3.19M 10-Q · filed 2015-08-07 | $3.19M 10-Q · filed 2014-08-11 | $4.57M derived: sum of 3 quarters · filed 2017-02-22 | $5.86M derived: sum of 4 quarters · filed 2017-02-22 | ||
| 2014-03-31 | $1.39M 10-Q · filed 2015-05-01 | $1.39M 10-Q · filed 2014-05-12 | $2.77M derived: sum of 2 quarters · filed 2017-02-22 | $4.06M derived: sum of 3 quarters · filed 2017-02-22 | $4.99M derived: sum of 4 quarters · filed 2017-02-22 | |||
| 2013-12-31 | $1.38M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-22 | $2.67M derived: sum of 2 quarters · filed 2017-02-22 | $3.60M derived: sum of 3 quarters · filed 2017-02-22 | $4.84M 10-K · filed 2017-02-22 | $4.84M 10-K · filed 2014-03-04 | |||
| 2013-09-30 | $1.29M 10-Q · filed 2014-11-10 | $2.21M derived: sum of 2 quarters · filed 2014-11-10 | $3.46M 10-Q · filed 2014-11-10 | $4.59M derived: sum of 4 quarters · filed 2015-03-13 | ||||
| 2013-06-30 | $924.47K 10-Q · filed 2014-08-11 | $2.17M 10-Q · filed 2014-08-11 | $3.31M derived: sum of 3 quarters · filed 2015-03-13 | $4.15M derived: sum of 4 quarters · filed 2015-03-13 | ||||
| 2013-03-31 | $1.25M 10-Q · filed 2014-05-12 | $2.38M derived: sum of 2 quarters · filed 2015-03-13 | $3.22M derived: sum of 3 quarters · filed 2015-03-13 | $3.72M derived: sum of 4 quarters · filed 2015-03-13 | ||||
| 2012-12-31 | $1.14M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-13 | $1.97M derived: sum of 2 quarters · filed 2015-03-13 | $2.48M derived: sum of 3 quarters · filed 2015-03-13 | $2.88M 10-K · filed 2015-03-13 | $2.88M 10-K · filed 2013-03-15 | |||
| 2012-09-30 | $838.69K 10-Q · filed 2013-11-08 | $1.34M derived: sum of 2 quarters · filed 2013-11-08 | $1.75M 10-Q · filed 2013-11-08 | $2.41M derived: sum of 4 quarters · filed 2014-03-04 | ||||
| 2012-06-30 | $503.09K 10-Q · filed 2013-08-08 | $910.16K 10-Q · filed 2013-08-08 | $1.57M derived: sum of 3 quarters · filed 2014-03-04 | $2.13M derived: sum of 4 quarters · filed 2014-03-04 | ||||
| 2012-03-31 | $407.07K 10-Q · filed 2013-05-10 | $1.07M derived: sum of 2 quarters · filed 2014-03-04 | $1.63M derived: sum of 3 quarters · filed 2014-03-04 | $2.42M derived: sum of 4 quarters · filed 2014-03-04 | ||||
| 2011-12-31 | $660.59K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-04 | $1.22M derived: sum of 2 quarters · filed 2014-03-04 | $2.01M derived: sum of 3 quarters · filed 2014-03-04 | $2.98M 10-K · filed 2014-03-04 | $2.60M 10-K · filed 2012-03-29 | |||
| 2011-09-30 | $561.54K 10-Q · filed 2012-11-13 | $485.24K 10-Q · filed 2011-11-14 | $1.35M derived: sum of 2 quarters · filed 2012-11-13 | $2.32M 10-Q · filed 2012-11-13 | $2.00M 10-Q · filed 2011-11-14 | $2.90M derived: sum of 4 quarters · filed 2012-11-13 | ||
| 2011-06-30 | $791.95K 10-Q · filed 2012-08-14 | $662.49K 10-Q · filed 2011-08-04 | $1.75M 10-Q · filed 2012-08-14 | $1.51M 10-Q · filed 2011-08-04 | $2.34M derived: sum of 3 quarters · filed 2012-08-14 | $3.18M derived: sum of 4 quarters · filed 2012-08-14 | ||
| 2011-03-31 | $962.22K 10-Q · filed 2012-05-14 | $1.55M derived: sum of 2 quarters · filed 2012-05-14 | $2.39M derived: sum of 3 quarters · filed 2012-05-14 | $3.14M derived: sum of 4 quarters · filed 2012-05-14 | ||||
| 2010-12-31 | $585.29K derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-29 | $1.43M derived: sum of 2 quarters · filed 2012-03-29 | $2.18M derived: sum of 3 quarters · filed 2012-03-29 | $2.75M 10-K · filed 2012-03-29 | ||||
| 2010-09-30 | $842.93K 10-Q · filed 2011-11-14 | $1.60M derived: sum of 2 quarters · filed 2011-11-14 | $2.17M 10-Q · filed 2011-11-14 | |||||
| 2010-06-30 | $752.71K 10-Q · filed 2011-08-04 | $1.33M 10-Q · filed 2011-08-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B | |
| SS Innovations International, Inc. (SSII) | $0.589B | -64.06 | |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| CERUS CORP (CERS) | United States | $0.525B | -86.40 |
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |
| NeuroPace Inc (NPCE) | United States | $0.480B | -28.52 |
| Sight Sciences, Inc. (SGHT) | United States | $0.478B | -9.95 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B |